http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-66336-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffd303a14d7f681fb9e2806f059bd649 |
| filingDate | 2003-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9608f0b5501fb103663c429f71c6a949 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26d428c95b4102169a03f5cdf264b58a |
| publicationDate | 2004-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-66336-A |
| titleOfInvention | METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS IN MODERATE ACTIVITY |
| abstract | A method for the treatment of chronic viral hepatitis B of moderate activity involves the use of a drug of hepatoprotective and antioxidant action, and hepatoprotective and antioxidant action is used, and hepa-merz is used first by intravenous drip in a dose of 10 g per day, which is dissolved in 200 ml of saline, for 7-9 days, and then orally 9 g per day in 3 divided doses 30 minutes before meals for 14-17 days. |
| priorityDate | 2003-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449839325 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18599 |
Total number of triples: 12.